Kate Bishop received a first class (hon) BSc in Biochemistry from the University of Bath following two research placements; one at the Karolinska Institute in Stockholm, Sweden and the other at Chiron Corporation in San Francisco, USA.
After completing her PhD studies with Jonathan Stoye working on the retroviral restriction factor, Fv1, she undertook postdoctoral training with Michael Malim at King's College London, investigating the APOBEC family of retroviral restriction factors. Kate was awarded a prestigious Royal Society Dorothy Hodgkin Fellowship in 2004 to continue her APOBEC research.
In 2008 she was simultaneously awarded a Wellcome Trust Career Development Fellowship and a group leader position at NIMR enabling her to broaden her research interests and investigate various aspects of the early stages of retroviral replication. Kate was awarded tenure at the Francis Crick Institute and promoted to senior group leader in 2017.
Recent outreach and public engagement:
- Guest speaker at the "Crick Chat" event on HIV (coming up, 2017)
- Interview by "Lab Times" publication (2017)
- Interviewed by BBC world service "Newsday" programme about The Crick and HIV (2016)
- Guest panellist on "The Conversation" on BBC World Service radio, a programme which brings together two extraordinary women each week, to talk about the profession or passion that connects them. Special edition recorded live at The Crick (2016)
- Interviewed by BBC news, BBC news 24, and London Live TV when The Crick first opened its doors (2016)
- Featured in The Observer newspaper's Tech Monthly supplement feature on the Crick (2016)
- Named as a Rising Star in the BioBeat 50 movers and shakers in biobusiness 2015 booklet, that recognises 50 outstanding women bioentrepreneurs and scientific leaders for their contributions to global health innovation (2015)